Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
| Molecular Weight | 1893.7 g/mol |
|---|---|
| Molecular Formula | C89H99Cl2N9O33 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 24 |
| Hydrogen Bond Acceptor Count | 34 |
| Rotatable Bond Count | 20 |
| Exact Mass | 1891.5722320 g/mol |
| Monoisotopic Mass | 1891.5722320 g/mol |
| Topological Polar Surface Area | 662 Ų |
| Heavy Atom Count | 133 |
| Formal Charge | 0 |
| Complexity | 3960 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 23 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Teicoplanin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Teicoplanin manufacturer or Teicoplanin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teicoplanin manufacturer or Teicoplanin supplier.
PharmaCompass also assists you with knowing the Teicoplanin API Price utilized in the formulation of products. Teicoplanin API Price is not always fixed or binding as the Teicoplanin Price is obtained through a variety of data sources. The Teicoplanin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Teicoplanin A2-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Teicoplanin A2-5, including repackagers and relabelers. The FDA regulates Teicoplanin A2-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Teicoplanin A2-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Teicoplanin A2-5 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Teicoplanin A2-5 supplier is an individual or a company that provides Teicoplanin A2-5 active pharmaceutical ingredient (API) or Teicoplanin A2-5 finished formulations upon request. The Teicoplanin A2-5 suppliers may include Teicoplanin A2-5 API manufacturers, exporters, distributors and traders.
click here to find a list of Teicoplanin A2-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Teicoplanin A2-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of Teicoplanin A2-5 active pharmaceutical ingredient (API) in detail. Different forms of Teicoplanin A2-5 DMFs exist exist since differing nations have different regulations, such as Teicoplanin A2-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Teicoplanin A2-5 DMF submitted to regulatory agencies in the US is known as a USDMF. Teicoplanin A2-5 USDMF includes data on Teicoplanin A2-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Teicoplanin A2-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Teicoplanin A2-5 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Teicoplanin A2-5 Drug Master File in Japan (Teicoplanin A2-5 JDMF) empowers Teicoplanin A2-5 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Teicoplanin A2-5 JDMF during the approval evaluation for pharmaceutical products. At the time of Teicoplanin A2-5 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Teicoplanin A2-5 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Teicoplanin A2-5 Drug Master File in Korea (Teicoplanin A2-5 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Teicoplanin A2-5. The MFDS reviews the Teicoplanin A2-5 KDMF as part of the drug registration process and uses the information provided in the Teicoplanin A2-5 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Teicoplanin A2-5 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Teicoplanin A2-5 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Teicoplanin A2-5 suppliers with KDMF on PharmaCompass.
A Teicoplanin A2-5 CEP of the European Pharmacopoeia monograph is often referred to as a Teicoplanin A2-5 Certificate of Suitability (COS). The purpose of a Teicoplanin A2-5 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Teicoplanin A2-5 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Teicoplanin A2-5 to their clients by showing that a Teicoplanin A2-5 CEP has been issued for it. The manufacturer submits a Teicoplanin A2-5 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Teicoplanin A2-5 CEP holder for the record. Additionally, the data presented in the Teicoplanin A2-5 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Teicoplanin A2-5 DMF.
A Teicoplanin A2-5 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Teicoplanin A2-5 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Teicoplanin A2-5 suppliers with CEP (COS) on PharmaCompass.
A Teicoplanin A2-5 written confirmation (Teicoplanin A2-5 WC) is an official document issued by a regulatory agency to a Teicoplanin A2-5 manufacturer, verifying that the manufacturing facility of a Teicoplanin A2-5 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Teicoplanin A2-5 APIs or Teicoplanin A2-5 finished pharmaceutical products to another nation, regulatory agencies frequently require a Teicoplanin A2-5 WC (written confirmation) as part of the regulatory process.
click here to find a list of Teicoplanin A2-5 suppliers with Written Confirmation (WC) on PharmaCompass.
Teicoplanin A2-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Teicoplanin A2-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Teicoplanin A2-5 GMP manufacturer or Teicoplanin A2-5 GMP API supplier for your needs.
A Teicoplanin A2-5 CoA (Certificate of Analysis) is a formal document that attests to Teicoplanin A2-5's compliance with Teicoplanin A2-5 specifications and serves as a tool for batch-level quality control.
Teicoplanin A2-5 CoA mostly includes findings from lab analyses of a specific batch. For each Teicoplanin A2-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Teicoplanin A2-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (Teicoplanin A2-5 EP), Teicoplanin A2-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Teicoplanin A2-5 USP).
